Project Details
| Status | Active |
|---|---|
| Effective start/end date | 9/21/22 → … |
A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab Versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-322)
- Shah, Shilpan (PI)
- Ganguly, Siddhartha (Key Personnel)
- Petkova, Jenny (Key Personnel)
- Pingali, S. Ravi (Key Personnel)
- Rice, Lawrence (Key Personnel)
Project: Clinical Trial